Huluwa Pharmaceutical Signs Strategic Cooperation Deals with Three Major Pharmacy Chains
Huluwa Pharmaceutical signed strategic cooperation framework agreements with three national pharmacy chains - Laobaixing Pharmacy, Yifeng Pharmacy and Yixintang Pharmaceutical - at the 2026 Xipu Conference on August 13. The partnerships span brand building, category coordination and terminal empowerment, covering joint brand campaigns, health education projects, children's health zones in stores, promotion of core pediatric medications, expanded family health product offerings, and professional training with digital tools to enhance store operations.
On August 13, at the 2026 Xipu Conference, Huluwa Pharmaceutical reached strategic cooperation agreements with three major national pharmacy chains - Laobaixing Pharmacy, Yifeng Pharmacy and Yixintang Pharmaceutical - and completed the signing. The strategic cooperation framework agreements cover routine collaborative efforts across multiple dimensions.
In brand building, the parties will jointly launch brand campaigns, implement linked marketing and health education projects, and set up children's health zones in stores. In category coordination and expansion, core pediatric medications will be designated as key promoted products in stores, while the supply of full-category family health products will be enriched, with exploration of channel-customized product collaborations.
In terminal empowerment, the partners will deliver systematic professional training and digital operation tools to enhance stores' refined management and professional service capabilities. The cooperation spans multiple business levels across the three pharmacy chain channels, and related arrangements will be progressively implemented in accordance with the agreement terms.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Pharmacy Retail, with intensity 50/100 and 70% confidence over a short term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.